Introduction {#sec1}
============

Advances in medicine, particularly in the diagnosis and treatment of cardiovascular diseases, have contributed to the increase in the number of elderly patients referred to cardiologists. Coronary artery calcification increases with age, and among patients undergoing percutaneous coronary intervention (PCI), it is present in about 30% of cases on angiographic assessment, and up to 70% of cases on intravascular ultrasound \[[@cit0001]\].

Revascularization in patients with heavily calcified coronary arteries can pose a challenge for interventional cardiologists. Calcified lesions often create problems during PCI and require the use of more aggressive techniques, typically associated with a greater risk of complications \[[@cit0002], [@cit0003]\]. The procedural success rate in these patients can be improved by using rotational atherectomy (RA), which is a technique that modifies the atherosclerotic plaque and facilitates stent delivery and implantation. The European Society of Cardiology guidelines on coronary revascularization, based on the ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) study, discuss the possibility of using RA in patients with significantly stenosed and calcified lesions but recommend against the routine use of this method \[[@cit0004], [@cit0005]\]. Rotational atherectomy can be performed electively or as a "bailout" procedure after unsuccessful angioplasty.

Aim {#sec2}
===

Few published reports have compared the outcomes of RA after unsuccessful angioplasty and RA performed electively. Therefore, the aim of this study was to compare early and late outcomes in patients who underwent RA as a bailout or elective procedure.

Material and methods {#sec3}
====================

We analyzed 156 consecutive patients hospitalized at a high-volume PCI center between 2009 and 2016 who underwent RA. All patients were included in an ongoing, prospective registry of RA procedures.

In 43 (27.6%) patients designated as group 1, RA was performed on an elective basis (primary RA). Elective RA was defined as the initial use of RA without previous device failure. In 113 (72.4%) patients designated as group 2, RA was carried out after unsuccessful traditional angioplasty (inability to cross the lesion with a balloon or stent -- 25.7%, balloon underexpansion -- 74.3%) -- secondary RA.

Coronary angiography was performed according to the standard institutional protocol. The degree of calcification was classified according to the Mintz criteria as mild, moderate, or severe \[[@cit0003]\]. The decision to perform elective RA or conventional angioplasty was left to the discretion of the operator and was usually based on the angiographic appearance of the target lesion. Heavy calcifications or effects of PCI previously performed on other lesions most likely influenced the operator's decision. Selection bias between the primary and secondary RA strategy often depended on operator experience. However, as this is a retrospective study, we do not have full data explaining the operator's decision.

To prevent bradyarrhythmias, a temporary electrode was inserted into the right ventricle before carrying out RA in the right coronary artery (RCA), the circumflex branch (in the case of a dominant left coronary arterial system), or in selected cases of multivessel coronary artery disease. The procedure was performed using a Rotablator system (Boston Scientific Scimed, Maple Grove, MN, US) with a burr size ranging from 1.25 to 2.25 mm. Based on current evidence, the burr diameter was selected so as to achieve a burr/artery ratio \< 0.7 \[[@cit0006], [@cit0007]\]. The rotation speed of the burr during RA ranged between 130 000 and 150 000 rpm. Short (10--25-second) sessions of RA were preferred. All patients without contraindications received drug-eluting stents (DES). Procedural success was defined as successful stent implantation with residual stenosis of less than 20% diameter and TIMI-3 flow. Periprocedural myocardial infarction (MI) was diagnosed according to the current recommendations \[[@cit0008]\]. All patients received dual antiplatelet therapy (aspirin and clopidogrel, ticagrelor, or prasugrel), which was then continued for at least 12 months after DES implantation and 4 weeks after implantation of a bare metal stent (BMS). During the procedure, anticoagulant therapy (unfractionated heparin) was administered, and use of IIb/IIIa inhibitors was left to the discretion of the operator. Quantitative coronary angiography (QCA) of the lesions was performed by two independent interventional cardiologists.

Patients' demographic characteristics, medical history, and clinical data were retrieved from the electronic patient record database at our institution. The following variables were analyzed: cardiovascular risk factors, angiographic characteristics, and type of equipment used during the procedure.

The primary endpoint was in-hospital and 12-month all-cause mortality. Secondary endpoints included myocardial infarction, the need for repeat target vessel revascularization (TVR) or revascularization of the treated lesion (TLR), stroke, and all major adverse cardiovascular events (MACE), which consisted of death, MI, TVR, TLR, and stroke. The follow-up data were obtained from the official National Health Fund database as well as from direct phone calls to patients or their families. We did not obtain data on cause of death.

Statistical analysis {#sec3.1}
--------------------

Continuous variables are presented as mean and standard deviation and compared using Student's *t*-test and Mann-Whitney *U*-test. Categorical variables are presented as numbers and percentages and compared using the χ^2^ test. Twelve-month mortality was analyzed with Kaplan-Meier curves and compared using the log-rank test. The logistic regression method was used to determine independent predictors of 12-month mortality. Multivariate models were constructed by including all univariate predictors with a *p*-value \< 0.2. Nonsignificant covariates were removed from the model in a backward stepwise fashion until all variables left in the model were statistically significant.

Results {#sec4}
=======

Patients in the two groups did not differ with regard to sex, age, or cardiovascular risk factors. Patients undergoing RA after unsuccessful angioplasty (group 2) more often had a history of previous coronary interventions. The baseline characteristics of both groups are listed in [Table I](#t0001){ref-type="table"}. Patients in group 1 more often had a history of peripheral artery disease. Mean EuroSCORE II was higher in group 1. Group 1 was dominated by patients with multivessel coronary artery disease. There were more ostial, bifurcation and longer lesions treated in group 1 ([Table II](#t0002){ref-type="table"}). In both groups, RA was performed most frequently in the RCA, while left main coronary artery (LMCA) RA was performed more often in the elective group. As most of the RA procedures were performed on the RCA, a temporary electrode was implanted in 53.2% of patients and the rate was similar in both groups. There were no complications related to electrode implantation. The success rates in the two groups were similar.

###### 

Baseline clinical characteristics

  Parameter                                            Elective RA (*n* = 43)   Bailout RA (*n* = 113)   *P*-value
  ---------------------------------------------------- ------------------------ ------------------------ -----------
  Male                                                 27 (62.8%)               74 (65.5%)               0.75
  Age \[years\]                                        71.0 ±8.2                69.0 ±8.7                0.71
  Hypertension                                         39 (91.2%)               95 (84.1%)               0.2
  Diabetes                                             21 (48.8%)               57 (50.4%)               0.88
  Diabetes on insulin                                  9 (20.93%)               20 (17.7%)               0.65
  Dyslipidaemia                                        33 (76.7%)               81 (71.7%)               0.48
  Chronic kidney disease eGFR \< 60 ml/min/1.73 m^2^   10 (23.3%)               28 (24.8%)               0.84
  Atrial fibrillation                                  13 (30.9%)               25 (23.2%)               0.56
  Peripheral vascular disease                          14 (32.6%)               18 (15.9%)               0.03
  EuroSCORE 2 mean                                     5.9 ±6.9                 4.6 ±7.0                 0.02
  History of stroke                                    4 (9.3%)                 13 (11.5%)               0.7
  Smoker                                               11 (26.19%)              30 (28.04%)              0.98
  Obesity                                              17 (39.5%)               41 (36.3%)               0.74
  Body mass index, mean ± SD                           29.12 ±5.4               28.88 ±4.47              0.21
  Family history of CAD                                15 (35.7%)               40 (37.4%)               0.99
  Previous MI                                          27 (62.8%)               77 (68.1%)               0.60
  Previous PCI                                         22 (51.2%)               84 (74.3%)               0.006
  Previous CABG                                        10 (23.3%)               29 (25.7%)               0.7
  ACS (UA + NSTEMI)                                    14 (32.6%)               31 (27.4%)               0.58
  Ejection fraction, mean ± SD \[%\]                   42.5 ±11.0               44.9 ±10.7               0.84
  Ejection fraction \< 35%                             8 (18.6%)                22 (19.5%)               0.84
  Hospitalization time, mean ± SD \[days\]             11.05 ±8.82              8.61 ±5.68               0.05
  RA during the same procedure                         11 (25.6%)               15 (13.3%)               0.65
  Delayed RA                                           32 (74.4%)               98 (86.7%)               0.17

CAD -- coronary artery disease, MI -- myocardial infarction, PCI -- percutaneous coronary intervention, CABG -- coronary artery bypass grafting, UA -- unstable angina, NSTEMI -- non-ST elevation myocardial infarction, RA -- rotational atherectomy.

###### 

Angiographic features

  Parameter                                   Elective RA (*n* = 43)   Bailout RA (*n* = 113)   *P*-value
  ------------------------------------------- ------------------------ ------------------------ -----------
  Three-vessel disease                        27 (62.8%)               38 (33.6%)               0.001
  Left main RA                                11 (25.6%)               3 (2.7%)                 \< 0.001
  RCA RA                                      18 (41.9%)               61 (54.0%)               0.18
  ACC AHA classification lesion type B/C      43 (100.0%)              113 (100.0%)             --
  Severe calcifications                       41 (95.3%)               94 (83.1%)               0.15
  Bifurcation lesion                          14 (32.6%)               10 (8.9%)                0.001
  Chronic total occlusion                     0                        5 (4.42%)                0.32
  Ostial lesion                               15 (34.9%)               19 (18.8%)               0.02
  Lesion length, mean ± SD \[mm\]             31.2 ±24.1               28.9 ±18.6               0.04
  Lesion length \> 20 mm                      22 (51.2%)               66 (58.4%)               0.34
  \% stenosis in QCA                          76.0 ±9.3                79.2 ±9.8                0.75
  MLD \[mm\]                                  0.77 ±0.37               0.62 ±0.33               0.32
  Reference diameter \[mm\]                   3.24 ±0.64               2.98 ±0.51               0.02
  Temporary electrode in right ventricle      24 (55.8%)               59 (52.2%)               0.75
  Femoral approach                            35 (81.4%)               101 (89.4%)              0.18
  7-French guiding catheter                   27 (62.8%)               83 (73.5%)               0.39
  Burr size in first step, mean ± SD \[mm\]   1.68 ±0.38               1.57 ±0.25               0.21
  No. of RA sessions                          4.0 ±1.41                3.93 ±1.72               0.16
  No. of burrs, mean ± SD                     1.40 ±0.49               1.32 ±0.47               0.64
  \> 1 burr                                   17 (39.5%)               36 (38.1%)               0.37
  Burr-to-artery ratio, mean ± SD             0.52 ±0.098              0.54 ±0.094              0.56
  Predilatation                               42 (97.7%)               113 (100%)               0.96
  Number of stents, mean ± SD                 1.86 ±1.03               1.92 ±1.03               0.52
  Total stent length \[mm\]                   47.84 ±25.71             43.26 ±23.69             0.33
  Drug-eluting stent                          40 (93.0%)               102 (90.3%)              0.73
  Postdilatation                              38 (88.4%)               84 (79.2%)               0.12
  GP IIb/IIIa inhibitor                       6 (14.0%)                13 (11.5%)               0.35
  Procedure time \[min\]                      146.34 ±40.17            135.47 ±46.15            0.09
  Fluoroscopy time \[min\]                    35.59 ±17.78             36.24 ±17.61             0.76
  Radiation dose \[Gy\]                       2.26 ±1.04               2.33 ±1.38               0.71
  Final TIMI-3 flow                           41 (95.4%)               109 (96.5%)              0.75
  MLD after procedure \[mm\]                  3.08 ±0.71               2.89 ±0.62               0.27
  Acute lumen gain, mean \[mm\]               2.31 ±0.63               2.27 ±0.61               0.78
  Procedural success                          40 (93.0%)               103 (91.2%)              0.71

RA -- rotational atherectomy, QCA -- quantitative coronary angiography, MLD -- minimal lumen diameter.

The rate of in-hospital complications did not differ significantly between groups. There was one case of in-hospital death in group 1 (2 days after the procedure). The incidence of periprocedural MI was similar in both groups. One patient in group 1 was diagnosed with ischemic stroke 1 day after the procedure ([Table III](#t0003){ref-type="table"}). There was no difference in the 12-month survival rate (86.1% vs. 92.0%, *p* = 0.27; [Figure 1](#f0001){ref-type="fig"}), and the secondary endpoints also occurred with similar frequency in both groups ([Table III](#t0003){ref-type="table"}).

###### 

Rate of in-hospital and 12-month adverse events

  Parameter                                               Elective RA (*n* = 43)   Bailout RA (*n* = 113)   *P*-value
  ------------------------------------------------------- ------------------------ ------------------------ -----------
  In-hospital complications:                                                                                
   Dissection                                             2 (4.7%)                 4 (3.5%)                 0.67
   Slow flow/no flow                                      2 (4.7%)                 4 (3.5%)                 0.67
   Rotawire fracture                                      0                        1 (0.9%)                 0.54
   Perforation                                            0                        2 (1.8%)                 0.93
   Access site complications (hematoma, pseudoaneurysm)   5 (11.6%)                4 (3.9%)                 0.20
   Periprocedural MI                                      2 (4.7%)                 5 (4.4%)                 0.95
   Stroke                                                 0                        1 (0.9%)                 0.54
   MACE                                                   3 (7.0%)                 6 (5.3%)                 0.69
   Death                                                  1 (2.3%)                 0                        0.10
  12-month complications:                                                                                   
   TLR                                                    1 (2.3%)                 6 (5.3%)                 0.42
   TVR                                                    2 (4.7%)                 8 (7.1%)                 0.58
   MI                                                     2 (4.7%)                 8 (7.1%)                 0.58
   Stroke                                                 0                        1 (0.9%)                 0.54
   MACE                                                   7 (16.3%)                17 (15.0%)               0.8
   Death                                                  6 (14.0%)                9 (8.0%)                 0.27

RA -- rotational atherectomy, MI -- myocardial infarction, TLR -- target lesion revascularization, TVR -- target vessel revascularization, MACE -- major adverse cardiac events.

![Kaplan-Meier 12-month survival curves in patients undergoing elective RA and RA after unsuccessful PCI](PWKI-14-33019-g001){#f0001}

Independent risk factors of all-cause mortality following RA were: left ventricular ejection fraction \< 35%, creatinine level at discharge and age ([Table IV](#t0004){ref-type="table"}).

###### 

Independent predictors of 12-month mortality

  Variable                Hazard ratio   95% confidence interval   Multivariate analysis (*p*-value)
  ----------------------- -------------- ------------------------- -----------------------------------
  ACS on admission        2.795          1.065--6.339              0.07
  Arterial hypertension   0.131          0.056--1.776              0.191
  LVEF \< 35%             3.287          1.540--7.018              0.02
  Creatinine level        1.016          1.002--1.029              0.021
  Age                     1.131          1.021--1.253              0.019

ACS -- acute coronary syndrome, LVEF -- left ventricular ejection fraction.

Discussion {#sec5}
==========

Coronary calcifications are often a part of systematic vessel calcinosis \[[@cit0009]\]. The treatment of calcified coronary lesions is associated with a high risk of restenosis and TLR \[[@cit0010]\]. Rotational atherectomy represents an alternative for patients with calcified arteries. Since its development nearly 30 years ago, the idea of an isolated RA \[[@cit0011]\] was quickly abandoned; however, in the DES era this method has seen a resurgence of interest as it has been associated with significantly reduced restenosis rates \[[@cit0012], [@cit0013]\]. Rotational atherectomy is often performed electively, but in everyday clinical practice RA is more widely performed as a secondary treatment after unsuccessful conventional angioplasty. The results, in the context of their clinical implications, arising from the present study are, first, that more than 70% of patients treated with RA at a center with extensive experience in interventional treatment underwent the procedure secondary to an ineffective attempt at conventional PCI; secondly, RA was performed in patients considered to be high risk in the context of clinical as well as angiographic characteristics; thirdly, RA as a technique demonstrated high efficacy and was associated with relatively few complications; fourthly, there were no significant differences in outcomes at 1 year after the procedure between patients who underwent RA after unsuccessful PCI and those who underwent RA electively.

Recently, several studies have reported the outcomes of DES implantation preceded by RA. Our patient cohort seems to represent a higher-risk group than previously reported, especially with regard to the presence of low ejection fraction and history of MI or coronary artery bypass grafting (CABG). Compared to the study of Clavijo *et al*. or Abdel-Wahab *et al.*, our cohort included higher proportion(s) of patients with diabetes or a history of MI, and we also attempted to treat longer lesions in coronary arteries \[[@cit0014], [@cit0015]\]. Similarly, the ROTATE study also included fewer patients with diabetes mellitus, low ejection fraction, or previous MI, PCI, or CABG \[[@cit0016]\].

Despite the inclusion of high-risk patients, the effectiveness of RA in our cohort was good. The success rate of the procedure has been reported to range from 90 to 100%. Our success rate was in this range. Of note, our study had no exclusion criteria. In some previous studies, performing RA without stent implantation was an exclusion criterion, while in our study stent implantation was required. We adopted restrictive criteria for treatment effectiveness, using a residual stenosis threshold lower than that of other studies such as those reported by Naito, Abdul-Wahab, and Furuichi, which accepted residual stenosis \< 30% \[[@cit0012], [@cit0015], [@cit0017]\]. The procedural success rate in our registry is comparable to that from the ROTATE registry (90.6%). Similar to the present study, in a comparison of 50 patients with severely calcified lesions who underwent RA at Zurich University Hospital, of whom 26 underwent elective rotablation due to the presence of severe calcifications on coronary angiography and 24 underwent rotablation secondary to failed conventional coronary intervention, there was no difference in efficacy between the elective and secondary RA groups \[[@cit0018]\].

The overall procedural complication rate in the present study also compares favorably with data reported in the literature. The dissection rate was lower than that reported in some previous studies \[[@cit0015]\]. The perforation rate was low and comparable to that presented in the Polish Registry \[[@cit0019]\]. Also the rate of in-hospital MI was relatively low compared to previous reports. The predominant use of femoral access causes frequent local complications but did not result in significant differences compared to other studies \[[@cit0014], [@cit0015]\]. We experienced one in-hospital death, as has been reported in some other studies \[[@cit0015]\].

The observed mortality rate at 12 months in the present study is similar to the rates reported in other published series of patients treated with RA. For example, Garcia de Lara *et al.* reported mortality rates at 12-month follow-up of 10% and 14% in the presence of MI, which is higher than in our registry \[[@cit0020]\]. In comparison to the ROTATE study, our cohort had a similar rate of MACE, but we also included stroke and TVR as endpoints. The incidence of MACE in the present study is lower than in the ROTAXUS study. Despite the high rate of angiographic success in the ROTAXUS cohort at 2-year follow-up, almost one-third of those patients experienced MACE, regardless of the treatment strategy \[[@cit0004], [@cit0021]\]. Of note, in the ROTAXUS study, patients with low ejection fraction, acute coronary syndrome, and unprotected left main disease were excluded. These differences allow us to conclude that the population of patients undergoing RA from our "all-comers" registry is more consistent with clinical reality than the randomized trial. It should be noted that in the ROTAXUS study, crossover to RA was necessary in 12.5% of patients in the group randomized to standard balloon dilatation before stenting. Thus, although the ROTAXUS study did not support the use of elective RA, the present analysis suggests that there is a need for further studies comparing primary and secondary RA in different patient populations.

Independent risk factors of all-cause mortality following RA were: left ventricular ejection fraction \< 35%, creatinine level at discharge and age. Impaired LVEF and renal disease were also independent risk factors of all-cause mortality in another study \[[@cit0022]\].

In our study the elective group had worse baseline and lesion characteristics such as higher EuroSCORE, higher prevalence of peripheral vascular disease, three-vessel disease, left main disease, bifurcation and ostial lesions, which probably caused the longer procedural time and lower survival rate. In the absence of comorbidities, most patients from the elective group would probably be referred for CABG due to multivessel and left main disease.

There are few reports comparing elective RA and RA after unsuccessful PCI. Compared to the previous study performed at Zurich University Hospital, the present study analyzed similar clinical characteristics but included more patients with a history of MI, PCI, or CABG and also did not find any significant differences between primary and secondary RA in terms of in-hospital and long-term outcomes. That previous study had better long-term results but the follow-up period was 6 months instead of 12. Compared to another study that enrolled 62 consecutive patients undergoing RA after ineffective conventional PCI, we observed better MI and MACE rates in the hospital and at follow-up \[[@cit0023]\].

In a different study whose aim was to compare outcomes of bailout and planned rotational atherectomy, 667 patients from the ROTATE study were analyzed. The main findings of this study were as follows: in-hospital outcomes were comparable between the two groups; the incidence of MACE at 1 year was significantly higher in the planned RA group amongst the unadjusted population with the differences between groups less marked after propensity-score adjustment; and the planned RA group benefited with regards to procedural outcomes with a reduction of procedural and fluoroscopy times, and number of predilation balloon catheters used \[[@cit0024]\].

A registry performed by Allali *et al.* compared primary and secondary RA. They concluded that elective RA was linked to a shortened RA procedural duration and a reduction of the rate of coronary dissections in selected lesions. However, this strategy does not influence long-term clinical outcomes. Similarly, we had a similar success rate and long-term outcomes. Noteworthy, our study population had a less favorable clinical profile with a high rate of previous PCIs \[[@cit0025]\].

Based on of these results, the elective and secondary RA strategy appears to be both feasible and safe, and should be considered as an option of treatment for calcified lesions. We are in need of further studies since there is little information on procedural, in-hospital, and long-term outcomes of bailout RA as compared to an elective strategy for complex calcified coronary lesions.

The present study has some limitations. It is a retrospective study, enrolling patients from a single center, and there is no control group. The study groups were relatively small, and the results need to be confirmed in a larger population or in a randomized trial.

Conclusions {#sec6}
===========

The analyzed data from our center indicate that RA treatment is associated with high efficacy and a relatively low risk of complications, and there is no advantage to either elective RA or RA after unsuccessful angioplasty at 12-month follow-up.
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